Cancer immunotherapy attempts to harness the immune system by breaking tolerance and generating a robust anticancer response. we have recently demonstrated a synergistic enhancement in tumor clearance following therapeutic, dual PD-1 and LAG-3 blockade. here, we discuss the implications of these fndings in the context of future combinatorial immunotherapeutic approaches.
|Original language||English (US)|
|Number of pages||3|
|State||Published - 2012|
ASJC Scopus subject areas
- Immunology and Allergy